Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-13

Clinical Trial Update: Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF

View source ↗

Summary

A clinical trial studying ventricular rate regularization in patients with congestive heart failure and atrial fibrillation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Davis | Conditions: Congestive Heart Failure, Atrial Fibrillation | Status: WITHDRAWN